We aimed to evaluate structure and functions of central nervous system (CNS) in children with glycogen storage disease (GSD) type 1a.
Glycogen storage diseases (GSD) are rare hereditary disorders affecting glycogen metabolism. Because of the defect of enzymes responsible for the synthesis or degradation of glycogen, abnormal accumulation of glycogen takes place in different organs; primarily in liver and muscles. There are over 12 types of GSD based on different enzyme deficiencies 1 .
Glycogen storage disease type 1 is the first identified metabolic disorder caused by an enzyme deficiency 2 . Glucose 6-phosphatase (G6Pase) enzyme catalyzes the terminal reaction of glycogenolysis and gluconeogenesis in hepatocytes, enterocytes and renal epithelial cells 3 . Deficient catalytic activity of the G6Pase system leads to GSD type 1a, which constitutes more than 80% of patients with GSD type 1. Its incidence is estimated to be around 1/100,000 births. GSD type 1a is characterized by impaired production of glucose from glycogenolysis and gluconeogenesis resulting in severe fasting hypoglycemia and increased production of lactic acid, triglyceride, and uric acid 4 .
Patients may present shortly after birth with hepatomegaly, hypoglycemia, tremor, irritability, apnea, seizure and lactic acidosis. They may also present later with doll like face, protuberant abdomen, lethargy, seizures and growth retardation. Anemia, bleeding tendency, diarrhea, and late onset puberty are other common findings. Patients especially with poor metabolic control have long-term complications such as short stature, developmental delay, seizures, intellectual disability, hepatic adenoma, renal dysfunction, gout and osteoporosis 5 . Frequent meals, continuous nocturnal drip-feeding and the administration of uncooked cornstarch are the treatment modalities commonly used either alone or in combination 6 . The aim of dietary treatment is to maintain normoglycemia and to prevent long-term complications of hypoglycemia. If hypoglycemia can be prevented, the biochemical and clinical abnormalities in most patients will improve 7 . However, in older patients, various complications may still develop. Although recurrent hypoglycemia occurs in disease course, severe central nervous system damage does not occur as severely as expected 8 . We aim to evaluate structure and function of central nervous system in a group of children with GSD type 1a on long-term follow up.
Material and Methods
This study was conducted at Hacettepe University Children's Hospital, Department of Pediatric Gastroenterology and Hepatology. Twenty-three patients with GSD type 1a were enrolled. All the patients were diagnosed previously by histopathological findings, glycogen amount, and G6Pase level in liver tissue according to criteria described by Narisawa et al. 9 Patients with history of prematurity, head trauma or any acute/chronic disease other than GSD type 1a
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Electroencephalography (EEG) recordings were obtained in 18 patients using the 10-20 International System with 24 channels bipolar montages (Nihon Kohden Inc, Japan). The EEG recording was carried out during awake state, and hyperventilation and photic stimulation were performed.
Visual evoked potentials (VEP): Subjects were placed 30 cm away from the monitor. The electrodes were placed on to the scalp according to [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] System. Both eyes were tested separately and the opposite eye was occluded during the test. Checkerboard pattern of black and white squares changing every 50 ms on the monitor were used as stimuli. The amplitudes and latencies of the P100 wave were evaluated in 21 patients and 21 controls.
Brainstem auditory evoked potentials (BAEP):
The test was performed in an acoustically isolated room. The electrodes were placed on to the scalp according to 10-20 International System. The click stimulus with rarefied polarity was monaurally presented at 75 dBHL in a speed of 10 stimuli per second, totaling 1024 stimuli per trace. The values of absolute interpeak I-V latencies were analyzed in 20 patients and 20 controls. The patients were assigned as good metabolic control if blood glucose was > 72 mg/dl, triglycerides < 531 mg/dl, uric acid < 6 mg/ dl, and lactate < 22.5 mg/dl. Additionally, number of hypoglycemic attacks (assigned as good if less than 5), and dietary compliance were also considered. Equal number of age and sex matched healthy subjects were taken as the control group for evoked potentials evaluation.
The results of the evaluations were compared between groups and correlated with parameters of metabolic control. 
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of P100 (Fig. 2) . Significant difference was observed between the patient and the control groups (p<0.001) but not between the good and poor metabolic control groups (p>0.05). Four of seven patients with VEP abnormalities were in poor metabolic control group.
Brain stem auditory evoked potentials were abnormal in 2/20 (10%) patients. Two patients had prolonged I-V interpeak latency and both were in poor metabolic control group (Fig. 3) . Significant difference was observed between the patient and the control groups (p<0.001) but not between the good and poor metabolic control groups (p>0.05).
Abnormal findings were detected on brain MRI of five patients (33%). All patients had bilateral mild white matter T2 hyperintensity. Diffuse periventricular and frontoparietal and occipital deep white matter was affected most frequently (n:4) and corpus callosum was additionally involved in one patient ( Fig. 1  A, B) . Diffusion weighted imaging showed restricted diffusion as revealed by low apparentdiffusion co-efficient maps in the patient with corpus callosum involvement ( Fig. 1 C-F) . Two patients had basal ganglia affected, millimetric cysts in the caudate nuclei in one and diffuse high signal intensity of the bilateral basal ganglia on both T1 and T2 WI in other. The patients with MRI abnormalities had frequent hypoglycemic attacks and seizures and all were in poor metabolic control group. Two patients with hypoglycemic convulsions in the newborn period who have also experienced hypoglycemic attacks during childhood had diffuse periventricular, frontoparietal and occipital deep white matter involvement on MRI.
A significant correlation was detected between the number of hypoglycemic attacks and MRI abnormalities. There were no correlations between the number of hypoglycemic attacks and presence of VEP, BAEP, and EEG abnormalities.
Discussion
Glucose metabolism provides the fuel for physiological brain function through the generation of ATP, the foundation for neuronal cellular maintenance, as well as the generation of neurotransmitters 11 . Patients with GSD type 1a have tolerance to hypoglycemia even at levels of blood sugar at which seizures would be expected, which could be due to utilization of lactic acid or ketone bodies by the brain and hypoinsulinemia secondary to chronic hypoglycemia 1 . There is only one study that evaluates CNS involvement in patients with GSD type 1. Melis et al. 12 reported neurological examination, psychometric tests, standard electroencephalogram, somatosensory, visual and brain-stem auditory evoked potentials and brain MRI results of nineteen patients with GSD type 1 consistent with variable degree of brain damage. In the present study, we report a systematic evaluation of CNS findings of a larger cohort of GSD type 1a patients on longterm follow up.
The incidence of ID is not as high as expected among GSD type 1a patients. Mental development was low in 3% and borderline in 18% in a European cohort of GSD type 1a patients 6 . Talente et al. 13 evaluated educational background of adult GSD type 1 a patients and reported only one patient with special education need. In our cohort, we detected ID in 33% of the patients, which is higher than the literature reports. These findings can be attributed to high number of patients with poor metabolic control in our cohort.
Pramming et al. 14 [20] [21] [22] . In addition to classic MRI findings seen in neonatal hypoglycemia, our findings are also compatible with adult type lesions seen following hypoglycemia. The frequent hypoglycemic attacks in our patients beyond the neonatal period, particularly in patients with poor metabolic control may be responsible for adult type hypoglycemic MRI findings.
Our study has some limitations. Although this is one of the largest cohort studies evaluating CNS in GSD type 1a, low patient number with CNS involvement remains as a limitation for statistical analysis. Additionally, poor patient compliance in young children was a challenge during VEP, BAEP and EEG studies. In five patients under 5 years we performed repeated measurements to overcome this limitation.
Evaluations including psychometric tests, EEG, VEP, BAEP and MRI demonstrated presence and patterns of CNS involvement in patients with GSD type 1a even with normal neurologic examination. Recurrent hypoglycemic episodes in neonatal period, infancy and childhood seem to play an important role in the pathogenesis of CNS involvement in GSD type 1a. Accumulation of abnormal results in poor metabolic control group suggests the importance of metabolic control in long-term outcome of these patients.
